Charles Cathlin

Charles Cathlin is the current CEO at Polaris Genomics. Prior to this, they were with Illumina Accelerator Alumni from May 2018 to October 2018. From March 2018 to April 2021, they were a Co-Founder/Board of Directors member at confinis. From October 2019 to July 2021, they were the Co-Founder/CEO at TruGenomix. Prior to that, they were with TruGenomix from January 2016 to July 2021 as a Co-Founder. Charles also served as the Chief of Staff at Defense and Veterans Brain Injury Center from April 2015 to April 2018 and as Deputy Chief of Staff from February 2014 to April 2015.

Charles Cathlin has a certificate in Executive Education in Entrepreneurship from Stanford University's Graduate School of Business, a certificate in Life Science Technology Commercialization from The Johns Hopkins University Carey Business School, a Master of Public Health in International Health from the Uniformed Services University of the Health Sciences, and a Bachelor of Science in Environmental/Environmental Health Engineering from the United States Air Force Academy.

Some individuals on their team include Amadeus Guchhait - Director, Marketing, Tshaka Cunningham - Chief Scientific Officer, and Frank Mastronuzzi - Chief Financial Officer.